CompletedPhase 4NCT04839692
Assessment and Augmentation of Lip Appearance in Specific Study Populations
Studying Lymphoid interstitial pneumonia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dieter Manstein, MD
- Principal Investigator
- Dieter Manstein, MD, PhDMassachusetts General Hospital
- Intervention
- Hyaluronic acid filler(drug)
- Enrollment
- 37 target
- Eligibility
- 21 years · FEMALE
- Timeline
- 2021 – 2022
Study locations (1)
- MGH Clinical Unit for Research Trials & Outcomes Research, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04839692 on ClinicalTrials.govOther trials for Lymphoid interstitial pneumonia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT060525013D Evaluation of the Lip Support in a Full-arch Implant-supported RehabilitationsImplantology Institute
- ACTIVE NOT RECRUITINGPHASE2NCT03529422Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHNUNC Lineberger Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT03854032Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and NeckThomas Jefferson University